GSK-3beta and alpha-catenin binding regions of beta-catenin exert opposing effects on the terminal ventral optic axonal projection

Dev Dyn. 2008 May;237(5):1434-41. doi: 10.1002/dvdy.21549.

Abstract

We overexpressed two deletion mutants of the N-terminal domain of beta-catenin in ventral optic axons in living Xenopus tadpoles. One deletion mutant contained both the alpha-catenin and the GSK-3beta binding sites of the N-terminal domain of beta-catenin (NTERM), and the second deletion mutant contained only the GSK-3beta binding site (beta-cat107). Expression of NTERM in ventral optic axons dispersed and induced anterior and lateral shifts in their targeting locations in the dorsal tectum. In contrast, beta-cat107 compressed and shifted the synaptic targeting locations of ventral optic axons medially and posteriorly. In addition, NTERM-expressing ventral optic axons formed arbors that were wider than controls whereas beta-cat107 axonal arbors were narrower compared with controls. These data suggest that the interactions of beta-catenin with alpha-catenin and GSK-3beta exert opposing effects on the terminal projections of ventral optic axons.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Axons / metabolism*
  • Axons / ultrastructure
  • Cell Movement / physiology*
  • Female
  • Glycogen Synthase Kinase 3 / genetics
  • Glycogen Synthase Kinase 3 / metabolism*
  • Glycogen Synthase Kinase 3 beta
  • Green Fluorescent Proteins / metabolism
  • Larva / anatomy & histology
  • Larva / physiology
  • Male
  • Protein Binding
  • Protein Structure, Tertiary
  • Retina / cytology*
  • Superior Colliculi / anatomy & histology
  • Superior Colliculi / physiology
  • Xenopus laevis* / anatomy & histology
  • Xenopus laevis* / physiology
  • alpha Catenin / genetics
  • alpha Catenin / metabolism*
  • beta Catenin / genetics
  • beta Catenin / metabolism*

Substances

  • alpha Catenin
  • beta Catenin
  • Green Fluorescent Proteins
  • Glycogen Synthase Kinase 3 beta
  • Glycogen Synthase Kinase 3